Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Axxcess Wealth Management LLC

Axxcess Wealth Management LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,888 shares of the medical equipment provider's stock after selling 594 shares during the quarter. Axxcess Wealth Management LLC's holdings in Intuitive Surgical were worth $4,402,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Brighton Jones LLC increased its position in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG boosted its stake in shares of Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after purchasing an additional 883 shares in the last quarter. Proficio Capital Partners LLC increased its holdings in Intuitive Surgical by 70.9% during the fourth quarter. Proficio Capital Partners LLC now owns 1,820 shares of the medical equipment provider's stock valued at $950,000 after buying an additional 755 shares during the period. Moran Wealth Management LLC raised its stake in Intuitive Surgical by 1.7% in the fourth quarter. Moran Wealth Management LLC now owns 1,778 shares of the medical equipment provider's stock worth $928,000 after buying an additional 29 shares in the last quarter. Finally, Independent Advisor Alliance raised its stake in Intuitive Surgical by 22.9% in the fourth quarter. Independent Advisor Alliance now owns 11,946 shares of the medical equipment provider's stock worth $6,235,000 after buying an additional 2,226 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $13.99 on Friday, reaching $512.06. 2,951,229 shares of the company's stock traded hands, compared to its average volume of 1,679,961. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00. The firm has a market cap of $183.53 billion, a price-to-earnings ratio of 75.08, a P/E/G ratio of 5.58 and a beta of 1.64. The stock has a 50 day moving average price of $537.85 and a 200-day moving average price of $536.69.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter last year, the business posted $1.50 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president directly owned 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last ninety days. Insiders own 0.70% of the company's stock.

Analyst Ratings Changes

ISRG has been the topic of several recent research reports. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Truist Financial decreased their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Finally, Royal Bank Of Canada cut their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $592.59.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.